Immediate Impact

2 by Nobel laureates 4 from Science/Nature 69 standout
Sub-graph 1 of 22

Citing Papers

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2025 Standout
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
1 intermediate paper

Works of Emer M. Brady being referenced

The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis
2015

Author Peers

Author Last Decade Papers Cites
Emer M. Brady 478 525 223 225 80 1.4k
Amber A. van der Heijden 502 325 254 358 71 1.9k
Ji Hee Yu 509 471 162 158 87 1.8k
Udai Nakamura 509 349 223 279 55 1.5k
Hannu Puolijoki 237 411 199 207 57 1.4k
Junping Wen 325 290 164 135 88 1.5k
Huiyong Zheng 839 342 147 494 51 2.1k
Sean Martin 592 796 72 234 70 2.1k
Matthew N. Cooper 599 467 95 119 83 2.1k
Ulla Rajala 539 276 288 139 64 1.6k
Raoul Rooman 574 421 264 158 56 1.6k

All Works

Loading papers...

Rankless by CCL
2026